Delivery Order SPE2DB22D1106-SPE2DB24FFHC2

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,281.19 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,407,541 methylphenidate ER 27 mg tablets in 100-count bottles. The ultimate completion date is November 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $1,336.44 to supply 4,565,890,480 tablets of 18 mg methylphenidate extended-release. The contract is a firm fixed-price delivery order with a completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to provide a wide range of essential medical products and...
This is a $1,135.20 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,404,218 units of 27 mg methylphenidate extended-release tablets. The order has an ultimate completion date of August 12, 2024. AmerisourceBergen is the prime contractor for this award, which is not set-aside. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,244,766 units of Methylphenidate ER 18 mg tablets. The $4,659.60 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,553,034 units of 5 mg Methylphenidate chewable tablets in 100-count bottles. The contract has a firm fixed price of $3,789.26 and a period of performance through March 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,760,196 units of Methylphenidate ER 18 mg tablets in 100-count packages, with a total ceiling value of $1,209.06. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at $1,633.48, is for the supply of 4,564,360,527 units of Methylphenidate ER 27 mg tablets in 100-count bottles. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 22, 2024, with a completion date of April 23, 2024. This delivery order is placed under Amerisourcebergen's existing...
This is a $1,291.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 4,567,875,730 units of Methylphenidate ER 27 mg tablets. The order has an ultimate completion date of April 14, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order is for the supply of Methylphenidate ER 18 mg tablets in 100 count packages, with a ceiling value of $3,853.32 and a completion date of June 10, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. As a significant...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFHC2
    Delivery Order

This is a $1,229.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,483,971 methylphenidate 5 mg tablets (100 count) with an ultimate completion date of August 19, 2024. This contract does not have a set-aside designation. Amerisourcebergen holds multiple indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives nationwide.

Generated 11/15/24, 9:07 AM